Your CDMO specialized in lentiviral vectors

Making the medicine of the future a reality

Our services

Experts in virology, we adapt ad-hoc to meet the specific requirements of your lentiviral vector.

Business model

GMP CDMO focused on different stages of the process.

Specialization

We work exclusively in lentivirus, offering comprehensive services.

Customized service

Technical adaptation and timely slot availability for each project.

Quality and safety

Compliance with EMA and FDA regulatory requirements.

Trusted by industry leaders

Vivebiotech in data

+40 customers

in the US, Europe, Asia and Australia

4x greater batch capacity

in reactor since 2020

4x increase in staff

since 2018

7 rooms dedicated

exclusively to lentivirus production

70% hold PhDs or bachelor's degrees

combining young talent and experience

About us

We are a Contract Development and Manufacturing Organization (CDMO) with over 40 biotech companies worldwide that have placed their trust in us.

Read more

Our value

VIVEbiotech is one of the only companies in the world specialized exclusively in lentiviral vectors. One of the things that sets us apart is our expertise not only in production but also virology, backed by a team of professionals with more than 30 years of experience.

Read more
See all news

Last news

6 March 2024

VIVEbiotech receives the EmakumeEkinn award for promoting innovation and female talent

On the occasion of the celebration of International Women's Day, the Sociedad Fomento San SebastiÃ...

Read more

14 December 2023

VIVEbiotech achieves significant business growth in 2023 with increases in demand for its lentiviral vector specialization and capabilities

VIVEbiotech today announces significant growth in 2023, with sales increasing by 70%.

Read more

With the support of